Physician profile
Mark A Hackbarth
NPI 1629071527
$1,037.69
in general payments reported to CMS, 2019-2025
9 companies · $40.80 in 2025
The $40.80 reported for 2025 was less than what a typical Addiction Medicine (Anesthesiology) provider received nationally (typical 2025 total: $133).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $819 · 2020: $114 · 2023: $13.70 · 2024: $50.02 · 2025: $40.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $546.01 | 2019-2023 | Eterna |
| Boston Scientific Corporation | $263.84 | 2019-2024 | Versacross Access Solution |
| Medtronic USA, INC. | $92.11 | 2019 | |
| Amgen INC. | $38.89 | 2019 | |
| Bioventus LLC | $27.65 | 2019 | |
| Novo Nordisk INC | $24.57 | 2025 | Wegovy |
| Sanofi-Aventis U.S. LLC | $16.23 | 2025 | |
| Nevro Corp. | $14.48 | 2024 | Senza |
| Ferring Pharmaceuticals INC. | $13.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hackbarth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.